Global Blood Therapeutics (GBT) shares lower; doctors said to question GBT440 at panel - Bloomberg
- Donald Trump Sworn in as 45th U.S. President
- U.S. stocks pare gains after Trump's inaugural speech
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Global Blood Therapeutics (NASDAQ: GBT) shares lower; doctors said to question GBT440 at panel - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Blood Therapeutics (GBT) Says First Patient Enrolled in Phase 3 HOPE Study in Sickle Cell Disease
- Active options: AAPL IBM ARNC FB BAC SWKS AMZN GE NFLX SGYP
- Puts with increasing volatility movement and volume: WBA RAD TDG